Viewing Study NCT03582618


Ignite Creation Date: 2025-12-25 @ 4:52 AM
Ignite Modification Date: 2025-12-26 @ 3:53 AM
Study NCT ID: NCT03582618
Status: TERMINATED
Last Update Posted: 2023-01-10
First Post: 2018-05-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma
Sponsor: TaiRx, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-07-12
Start Date Type: ACTUAL
Primary Completion Date: 2021-11-16
Primary Completion Date Type: ACTUAL
Completion Date: 2022-12-30
Completion Date Type: ACTUAL
First Submit Date: 2018-05-21
First Submit QC Date: None
Study First Post Date: 2018-07-11
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-01-06
Last Update Post Date: 2023-01-10
Last Update Post Date Type: ACTUAL